Clinical Trials Update: Oct. 7, 2009
Gout Schizophrenia Parkinson's Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study is evaluating an investigational medication for gout when used in combination with another medication.
The research site is in Dallas, Texas.
This 52-week study will evaluate long-acting injectable Aripiprazole. Participants must be 18 to 60 and be diagnosed with schizophrenia.
The research site is in Chandler, Ariz.
This study will evaluate the safety and effectiveness of an experimental treatment to reduce motor symptoms in people with advanced Parkinson's disease.
The research site is in Stanford, Calif.
Copyright 2009 ClinicalConnection.com. All rights reserved.